Neurotrack is transforming the diagnosis of Alzheimer’s disease. Through a safe and non-invasive test, its technology can predict the risk of developing mild cognitive impairment and Alzheimer’s disease years before symptoms occur.
Latest funding size
Time since last funding
|2 months ago|
|iSeed Ventures, Rock Health, Khosla Ventures, Social Capital, AME Cloud Partners, Founders Fund, AME Cloud Ventures, Sozo Ventures, Rethink Impact, Marc Benioff|